A study of malignant lymphomas in Iran, based on the updated Kiel classification

H Tabrizchi1, R K Gupta, M R Rafii

  • 1Department of Pathology, Kerman Medical School, Iran.

Virchows Archiv. A, Pathological Anatomy and Histopathology
|January 1, 1991
PubMed

Insights

This study analyzed 162 malignant lymphoma cases in Iran using immunohistology. Findings were compared to Western countries, revealing differences in non-Hodgkin

Area of Science:

  • Oncology
  • Pathology
  • Immunology

Background:

  • Malignant lymphomas represent a diverse group of lymphoid neoplasms.
  • Understanding the epidemiological distribution of lymphoma subtypes is crucial for diagnosis and treatment.
  • Previous data on lymphoma prevalence in the Middle East, particularly Iran, is limited.

Purpose of the Study:

  • To classify malignant lymphomas diagnosed in Iran based on the updated Kiel classification.
  • To determine the epidemiological distribution of non-Hodgkin's lymphoma subtypes in Iran.
  • To compare the observed lymphoma patterns in Iran with those reported in Western countries.

Main Methods:

  • Collection of 162 consecutive malignant lymphoma cases from two diagnostic centers in Iran.
  • Histopathological examination of tissue samples using immunohistological methods.
  • Classification of non-Hodgkin's lymphomas according to the updated Kiel classification.

Main Results:

  • Detailed classification of the 162 malignant lymphoma cases.
  • Analysis of the distribution of different non-Hodgkin's lymphoma subtypes within the Iranian cohort.
  • Comparative analysis highlighting variations in lymphoma subtype prevalence between Iran and Western populations.

Conclusions:

  • The study provides a comprehensive classification of malignant lymphomas in Iran.
  • Significant differences in the distribution of non-Hodgkin's lymphoma subtypes were observed compared to Western countries.
  • These findings underscore the importance of regional variations in lymphoma epidemiology.

Related Concept Videos